Covered recipient · General Payments record
KAYLEE MARIE POSTON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$3,190.57
- Reported across 140 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $432.84 | 15 |
| Education | $77.97 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.31 | 5 |
| Astellas Pharma US Inc | $130.85 | 4 |
| Axonics Modulation Technologies, Inc. | $126.57 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $36.63 | 2 |
| PFIZER INC. | $34.81 | 2 |
| UROGEN PHARMA, INC. | $25.22 | 1 |
| Sumitomo Pharma America, Inc. | $22.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.06 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032580 | CMS |
| ABBVIE INC. | $27.79 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032582 | CMS |
| ABBVIE INC. | $29.34 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032584 | CMS |
| ABBVIE INC. | $24.75 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032586 | CMS |
| ABBVIE INC. | $26.37 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032588 | CMS |
| Astellas Pharma US Inc | $19.82 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139519503 | CMS |
| Astellas Pharma US Inc | $77.97 | 07/25/2024 | Education | Undisputed | 01/23/2026 | 1139539958 | CMS |
| Astellas Pharma US Inc | $17.05 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139527890 | CMS |
| Astellas Pharma US Inc | $16.01 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139555157 | CMS |
| Axonics, Inc. | $126.57 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142378635 | CMS |
| Boston Scientific Corporation | $18.66 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092642807 | CMS |
| Boston Scientific Corporation | $17.97 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092642805 | CMS |
| PFIZER INC. | $17.19 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130877604 | CMS |
| PFIZER INC. | $17.62 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130877602 | CMS |
| Sumitomo Pharma America, Inc. | $22.42 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148988832 | CMS |
| UROGEN PHARMA, INC. | $25.22 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137926066 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.